Suppression of TAK1 pathway by shear stress counteracts the inflammatory endothelial cell phenotype induced by oxidative stress and TGF-beta 1 by Lee, Ee Soo et al.
  
 University of Groningen
Suppression of TAK1 pathway by shear stress counteracts the inflammatory endothelial cell
phenotype induced by oxidative stress and TGF-beta 1






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2017
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Lee, E. S., Boldo, L. S., Fernandez, B. O., Feelisch, M., & Harmsen, M. C. (2017). Suppression of TAK1
pathway by shear stress counteracts the inflammatory endothelial cell phenotype induced by oxidative
stress and TGF-beta 1. Scientific Reports, 7, [42487]. https://doi.org/10.1038/srep42487
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
1Scientific RepoRts | 7:42487 | DOI: 10.1038/srep42487
www.nature.com/scientificreports
Suppression of TAK1 pathway 
by shear stress counteracts the 
inflammatory endothelial cell 
phenotype induced by oxidative 
stress and TGF-β1
Ee Soo Lee1,†, Llorenç Solé Boldo1, Bernadette O. Fernandez2, Martin Feelisch2 & 
Martin C. Harmsen1
Endothelial dysfunction is characterised by aberrant redox signalling and an inflammatory phenotype. 
Shear stress antagonises endothelial dysfunction by increasing nitric oxide formation, activating anti-
inflammatory pathways and suppressing inflammatory pathways. The TAK1 (MAP3K7) is a key mediator 
of inflammation and non-canonical TGF-β signalling. While the individual roles of TAK1, ERK5 (MAPK7) 
and TGF-β pathways in endothelial cell regulation are well characterised, an integrative understanding 
of the orchestration of these pathways and their crosstalk with the redox system under shear stress 
is lacking. We hypothesised that shear stress counteracts the inflammatory effects of oxidative stress 
and TGF-β1 on endothelial cells by restoring redox balance and repressing the TAK1 pathway. Using 
human umbilical vein endothelial cells, we here show that TGF-β1 aggravates oxidative stress-mediated 
inflammatory activation and that shear stress activates ERK5 signalling while attenuating TGF-β 
signalling. ERK5 activation restores redox balance, but fails to repress the inflammatory effect of 
TGF-β1 which is suppressed upon TAK1 inhibition. In conclusion, shear stress counteracts endothelial 
dysfunction by suppressing the pro-inflammatory non-canonical TGF-β pathway and by activating 
the ERK5 pathway which restores redox signalling. We propose that a pharmacological compound 
that abates TGF-β signalling and enhances ERK5 signalling may be useful to counteract endothelial 
dysfunction.
The vascular endothelium is a monolayer of cells that acts as the regulatory interface between blood and the vessel 
wall. Given the capability to receive and respond to biochemical as well as biomechanical stimuli, the endothelium 
is a key regulator of cardiovascular homeostasis1. Adverse alterations of the endothelial phenotype (endothelial 
dysfunction) precede the pathogenesis of cardiovascular disorders, particularly atherosclerosis1,2 and pulmonary 
hypertension3. The maintenance of a healthy endothelial phenotype relies on a delicate balance between nitric 
oxide (NO) production and reactive oxygen species (ROS) formation, both of which are crucial to the mainte-
nance of cellular redox tone and the functioning of redox-related cell signalling. A decreased NO bioavailability, 
secondary to enhanced NO degradation by ROS can tip the redox balance and cause impaired NO-mediated sig-
nalling, an early hallmark of endothelial dysfunction2,4. In physiology, the phenotype of endothelial cells is tightly 
regulated by their responses to mechanical forces, especially shear stress5–7. Shear stress exerted by laminar blood 
flow increases NO bioavailability, while reducing ROS production. Therefore, shear stress safeguards endothelial 
redox homeostasis and counteracts endothelial dysfunction5,7,8.
The protective effects of shear stress on endothelial cells extend to its inhibition of inflammatory signalling cas-
cades, such as nuclear factor kappa-light-chain-enhancer of activated B cell (NFκ B)5,9 and p38 mitogen-activated 
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protein kinase (MAPK)10 pathways. The expression of inflammatory entities, such as adhesion molecules and 
chemoattractants, that are activated by these signalling pathways, is also inhibited by shear stress5–9. Shear 
stress also elicits its protective effects through activation of mitogen-activated protein kinase 7 (MAPK7), also 
known as extracellular signal-regulated kinase 5 (ERK5)7. ERK5 signalling downregulates inflammatory enti-
ties through induction of the anti-inflammatory transcription factors, Kruppel-like factor 2 (KLF2)11 or KLF412. 
Notably, TGF-β signalling also mediates shear-induced KLF2 expression through the activin receptor-like kinase 
5 (ALK5)/SMAD pathway13,14. While the individual roles of NFkB, p38 MAPK, ERK5 and TGF-β pathways in 
endothelial dysfunction are well delineated, an understanding of the orchestration of these pathways and their 
crosstalk with the redox system in the context of relevant haemodynamic forces remain obscure. In addition 
to activating the canonical SMAD pathway, TGF-β also activates the non-canonical mitogen-activated pro-
tein kinase kinase kinase 7 (MAP3K7), also known as TGF-β -activated kinase 1 (TAK1) pathway15. Activation 
of TAK1 by inflammatory cytokines induces the expression of inflammatory entities in endothelial cells9. 
Surprisingly, the consequences of TAK1 activation for endothelial cells upon TGF-β stimulation and its regula-
tion by shear stress remain unknown.
The levels of oxidative stress and TGF-β 1 increase upon vascular damage4,16. However, the molecular mecha-
nisms by which shear stress regulates the phenotype of endothelial cells upon oxidative stress and TGF-β 1 stimu-
lation are poorly understood. Our earlier studies revealed that shear stress suppresses a severe form of endothelial 
dysfunction, TGF-β -induced endothelial-to-mesenchymal transition (EndMT), through ERK5 activation17. Here, 
we hypothesised that shear stress counteracts the inflammatory effects of oxidative stress and TGF-β 1 on endothe-
lial cells by repressing the TAK1 pathway and by restoring redox balance. To test this hypothesis, we subjected 
human umbilical vein endothelial cells (HUVEC) to the pro-inflammatory (ROS) and pro-fibrotic (TGF-β 1) 
triggers, and dissected the associated cell signalling responses of ERK5, ALK5 and TAK1 to shear stress using a 
combination of molecular biological, biochemical and pharmacological tools.
Results
TGF-β1 aggravates the inflammatory effects of oxidative stress. Studies about the combined 
effects of bovine brain extract (referred to as endothelial cell growth factors, ECGF throughout the text) depriva-
tion and TGF-β 1 on redox balance and inflammation are scarce. Therefore, we investigated the influence of ECGF 
deprivation and TGF-β 1 stimulation on ROS and NO metabolites formation, as well as the subsequent expression 
of inflammatory molecules by HUVEC. ECGF deprivation caused a 1.6-fold increase of intracellular ROS for-
mation, but TGF-β 1 stimulation did not further affect ROS induction (Fig. 1A). Interestingly, ECGF deprivation 
also increased NO production as evidenced by an elevation of nitrite, nitrate and nitroso compounds, whereas 
TGF-β 1 had no added effect (Fig. 1B). Consistent with previous report18, these results demonstrate that increases 
in oxidative stress are counterbalanced by an up-regulation of endogenous NO production, and that TGF-β 1 has 
insignificant influence on this redox reaction.
The oxidative stress caused by ECGF deprivation was associated with an increase in the expression of 
inflammatory molecules, SELE (10.3-fold), ICAM1 (14.5-fold), VCAM1 (50-fold), CXCL8 (7.7-fold) and 
CCL2 (10.7-fold; Fig. 1C). Of note, TGF-β 1 caused an additional increase of CXCL8 expression (Fig. 1C). 
Oxidative stress alone or in conjunction with TGF-β 1 stimulation did not alter the expression of TNFA and 
IL1B. However, the combined stimulation with oxidative stress and TGF-β 1 increased IL6 expression by 1.7-fold 
(see Supplementary Fig. S1A). Oxidative stress induced the protein expression of ICAM-1 (2.7-fold), but there 
was no added effect of TGF-β 1 on this induction (Fig. 1D). Of note, oxidative stress alone did not alter the 
expression VCAM-1, while oxidative stress together with TGF-β 1 caused a 6-fold upregulation (Fig. 1E). TGF-β 
1 synergised with oxidative stress in inducing IL-8 secretion, as shown by the 2-fold higher induction of IL-8 
secretion upon treatment with TGF-β 1 compared to oxidative stress alone (Fig. 1F). These data indicate that 
dependent on the redox status of endothelial cells, the effects of TGF-β 1 on inflammatory molecules expression 
are variable. Endothelial cells stimulated by oxidative stress and TGF-β 1 had 27-fold higher interaction with 
leukocytes, as compared with the unstimulated control (see Supplementary Fig. S1B). Of note, this inflammatory 
endothelial phenotype was endowed with the feature of EndMT, as shown by the upregulation of mesenchy-
mal markers, ACTA2, TAGLN and CNN1, as well as the downregulation of PECAM1, THBD and NOS3 (see 
Supplementary Fig. S1C).
Laminar shear stress suppresses the inflammatory effects of oxidative stress and TGF-β1. To 
assess the regulation of endothelial phenotype by shear stress, we exposed endothelial cells to laminar shear stress 
at a magnitude of 20 dynes/cm2. Shear stress enhanced endothelial NO production (Fig. 2A), down-regulated the 
expression of SELE (3.3-fold), VCAM1 (1.4-fold), CXCL8 (19.2-fold) and CCL2 (23.8-fold), while up-regulated 
the expression of ICAM1 (2.3-fold; Fig. 2B). In agreement with the gene expression data, shear stress downregu-
lated VCAM-1 protein expression (Fig. 2C). IL-8 secretion did not change in response to shear stress (Fig. 2D).
Upon oxidative stress and additional TGF-β 1 stimulation, sheared endothelial cells had a 6-, 11.5-, 94- and 
42-fold downregulation of SELE, VCAM1, CXCL8 and CCL2 (Fig. 2E), respectively, when compared with the 
static control. Notably, shear stress repressed the upregulation of VCAM-1 (Fig. 2F) and IL-8 (Fig. 2G) protein 
expression by 12.7- and 5.3-fold, respectively. These data demonstrate that shear stress attenuates the combined 
inflammatory effects of oxidative stress and TGF-β 1, and this effect is likely mediated via an increase in NO 
production.
Activation of ERK5 reduces oxidative stress, but does not repress the inflammatory effects of 
TGF-β1. We were intrigued to elucidate as to how ERK5 signalling influences the combined effects of oxida-
tive stress and TGF-β 1, and vice versa in terms of endothelial phenotype regulation. To address this, we exam-
ined cellular redox state and phenotype of MEK5D-transduced cells subjected to oxidative stress and stimulated 
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with TGF-β 1. MEK5D is a constitutively active mutant of MEK5 that induces sustained activation of the ERK5 
pathway12. Sustained activation of ERK5 suppressed the generation of both, ROS (Fig. 3A) and NO production 
(Fig. 3B). TGF-β 1 did not alter the effects of ERK5 on maintenance of redox poise. Activation of ERK5 inhibited 
the expression of SELE, CXCL8 and CCL2, but up-regulated the expression of ICAM1 and VCAM1 (Fig. 3C). 
Upon treatment with TGF-β 1, expression of ICAM1 and VCAM1 in MEK5D-transduced cells were enhanced 
by 2- and 39-fold, respectively (Fig. 3C). Notably, TGF-β 1 synergised with the ERK5-mediated upregulation 
Figure 1. TGF-β1 aggravates the inflammatory effects of endothelial cell growth factor deprivation 
that induces oxidative stress. (A) Endothelial cell growth factor (ECGF) deprivation induces the formation 
of intracellular ROS (N = 3). TGF-β 1 has negligible effects on the production of ROS (N = 3). (B) ECGF 
deprivation induces the formation of NO metabolites, nitrite, nitrate and nitroso compounds (N = 3). TGF-β 
1 has minimal effects on the production of NO metabolites (N = 3). (C) Oxidative stress induces the gene 
expression of adhesion molecules (SELE, ICAM1 and VCAM1) and chemoattractants (CXCL8 and CCL2) as 
compared with unstimulated condition (shown as a dotted line; N = 3). TGF-β 1 augments the upregulation of 
CXCL8 (N = 3). (D) Oxidative stress induces the protein expression of ICAM-1 (N = 3). TGF-β 1 has little effect 
on the elevation of ICAM-1 expression (N = 3). Scale bar represents 50 μ m. The combined effect of oxidative 
stress and TGF-β 1 accentuates (E) the expression of VCAM-1 (N = 3) and (F) the secretion of IL-8 (N = 3). 
*p < 0.05, **p < 0.01, ***p < 0.001 & ****p < 0.0001.
www.nature.com/scientificreports/
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Figure 2. Shear stress preserves phenotype of endothelial cells. (A) Shear stress induces endothelial NO 
metabolites production, particularly nitrate and nitroso compounds (N = 3). (B) In comparison with the static 
condition (shown as a dotted line), shear stress inhibits the expression of SELE, VCAM1, CXCL8 and CCL2, 
but induces the expression of ICAM1 (N = 3). (C) Shear stress suppresses the protein expression of VCAM-1 as 
compared with the static condition (N = 6). (D) Shear stress has no effect on the secretion of IL-8 (N = 4).  
(E) Shear stress downregulates the elevated expression of SELE, VCAM1, CXCL8 and CCL2 (N = 3). Shear stress 
downregulates the increased expression of (F) VCAM-1 (N = 7) and (G) IL-8 (N = 4) resulted from oxidative 
stress and TGF-β 1 stimulation. Data are presented relative to the unstimulated static condition (shown as a 
dotted line). *p < 0.05, **p < 0.01, ***p < 0.001 & ****p < 0.0001.
www.nature.com/scientificreports/
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Figure 3. Endothelial cells stably expressing MEK5D are protected from oxidative stress, but have 
increased expression of ICAM-1 and VCAM-1 upon TGF-β1 stimulation. Endothelial cells transduced with 
a constitutively active mutant of MEK5 (MEK5D) produce lower level of (A) ROS and (B) NO metabolites than 
the vector control (N = 3). TGF-β 1 does not alter the effects of ERK5 on downregulating the generation of ROS 
and NO metabolites (N = 3). (C) Activation of ERK5 pathway downregulates the induced expression of SELE, 
CXCL8 and CCL2, but does not repress the elevation of ICAM1 and VCAM1 (N = 3). (D) ERK5 activation does 
not suppress the protein expression of ICAM-1 (N = 3). Scale bar represents 50 μ m. (E) TGF-β 1 intensifies the 
induced expression of VCAM-1 by ERK5 (N = 4). (F) Activation of ERK5 pathway suppresses the secretion of 
IL-8 (N = 4). *p < 0.05, **p < 0.01, ***p < 0.001 & ****p < 0.0001.
www.nature.com/scientificreports/
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of ICAM1 and VCAM1. In spite of the enhanced transcript expression, TGF-β 1 had negligible effect on protein 
expression of ICAM-1 in MEK5D-transduced cells (Fig. 3D). Activation of ERK5 induced the expression of 
VCAM-1 by a factor of 5 (Fig. 3E). Remarkably, upregulation of VCAM-1 was further enhanced (3.5-fold) when 
ERK5 pathway was activated upon TGF-β 1 stimulation (Fig. 3E). The TGF-β -induced IL-8 secretion was strongly 
inhibited (14.6-fold) when MEK5D was stably expressed (Fig. 3F). Collectively, our data indicate that despite the 
marked modulatory effects of ERK5 pathway on the magnitude of combined ROS and NO production, it only 
partially rescues the TGF-β 1-induced alterations in endothelial phenotype.
Shear stress antagonises the activation of canonical TGF-β signalling, independent of 
ERK5. Under stimulation with TGF-β 1, shear stress repressed, whereas ERK5 signalling augmented the 
expression of VCAM-1. These differences prompted us to dissect the underlying mechanisms. In spite of the 
TGF-β 1 stimulation, both sheared and MEK5D-transduced cells showed increased ERK5 phosphorylation, as 
well as enhanced KLF2 and KLF4 expression (Fig. 4A). Others reported that KLF2 attenuates canonical TGF-β 
signalling through reduction of SMAD2 phosphorylation and inhibition of SMAD3/4 transcriptional activity19. 
We therefore investigated whether shear stress downregulates canonical TGF-β signalling while induces KLF2 
expression via ERK5 activation. Our data show that TGF-β 1 stimulation induced SMAD2 phosphorylation, an 
effect that was repressed approximately 1.5-fold by shear (Fig. 4B). This repression was not caused by the reduced 
expression of total SMAD2 (Fig. 4B). Activation of ERK5 signalling under static conditions did not suppress 
the phosphorylation of SMAD2 (Fig. 4C). Upon stimulation with TGF-β 1, MEK5D-transduced cells showed 
a 2.3-fold higher phosphorylation of SMAD2 than the vector controls (Fig. 4C), implying that the TGF-β sig-
nalling was reinforced by activation of the ERK5 pathway, the mechanism of which is unclear. Sustained ERK5 
activation did not alter the expression of total SMAD2 (Fig. 4C). Furthermore, there was a 4-fold increased 
expression of SMAD2 target gene, TAGLN in MEK5D-transduced cells under stimulation with TGF-β 1 (see 
Supplementary Fig. S2). These results demonstrate that shear stress suppresses, whereas ERK5 signalling aug-
ments the activation of canonical TGF-β signalling.
Shear stress induced the expression of the TGF-β canonical inhibitors, SMAD6 and SMAD7 2.4- and 4.1-fold 
(Fig. 4D), respectively. Shear-induced SMAD6 and SMAD7 expression was not altered by TGF-β 1 stimulation 
(Fig. 4D). In concordance with shear stress, constitutive activation of ERK5 (MEK5D-transduced cells) under 
static condition enhanced the expression of SMAD6 and SMAD7 2.4- and 4.5-fold, respectively. Intriguingly, 
TGF-β 1 stimulation augmented the upregulation of SMAD6 and SMAD7 in MEK5D-transduced cells (Fig. 4E), 
supporting the notion that ERK5 signalling enhances the activation of TGF-β signalling. These data show that 
both shear stress and activation of ERK5 induce the expression of inhibitory SMADs (I-SMADs), i.e. SMAD6 and 
SMAD7.
Inhibition of canonical TGF-β signalling suppresses oxidative stress, but does not influence the 
expression of ICAM-1, VCAM-1 and IL-8. Since shear stress represses the activation of TGF-β signalling, 
we inhibited the canonical ALK5/SMAD pathway with the ALK5 inhibitor, SB431542, to investigate whether 
canonical TGF-β signalling affects redox balance and endothelial phenotype. Inhibition of ALK5/SMAD signal-
ling reduced ROS formation (1.3-fold; Fig. 5A), but had insignificant effect on NO production (Fig. 5B). ALK5/
SMAD signalling had no effect on the expression of SELE and VCAM1 (Fig. 5C). Notably, ICAM1, CXCL8 and 
CCL2 were almost 2-fold downregulated (Fig. 5C). Inhibition of the ALK5/SMAD signalling had no effects on 
the induced expression of ICAM-1 (Fig. 5D), VCAM-1 (Fig. 5E) and IL-8 (Fig. 5F) upon TGF-β 1 stimulation. 
Similarly, the expression of ICAM-1 (Fig. 5G) and VCAM-1 (Fig. 5H) in MEK5D-transduced cells was unaffected 
by the inhibition of ALK5. These data implicate a role for ALK5/SMAD signalling in ROS generation, but not in 
NO production and protein expression of inflammatory molecules.
Inhibition of TAK1 pathway or mitochondrial ROS production suppresses the upregulation of 
ICAM-1, VCAM-1 and IL-8. Because the inhibition of canonical ALK5/SMAD signalling did not suppress 
the induced expression of ICAM-1, VCAM-1 and IL-8, we hypothesised that shear stress inhibits the expression 
of these molecules by regulating either the non-canonical TAK1 pathway or redox poise. The TAK1 inhibitor, 
5z-7-oxozeaenol and the mitochondrial ROS inhibitor, YCG063, both reduced the formation of intracellular 
ROS by 1.2- and 1.4- fold, respectively (Fig. 6A). Inhibition of TAK1 and mitochondrial ROS reduced nitrate 
generation by 2.2- and 1.3-fold, respectively, but had insignificant effects on nitrite formation (Fig. 6B). Of note, 
the production of nitrosated species increased dramatically (more than 30-fold) as a result of mitochondrial ROS 
inhibition, in the presence (see Supplementary Fig. S3) and absence (Fig. 6B) of constitutive ERK5 activation; 
these effects were not accompanied by prominent enhanced nitrite/nitrate formation, indicating they were not 
caused by increased NO production. While both pathway of formation and functional significance of this finding 
remain unclear at present, this data are testimony to marked alterations in mitochondrial nitrosative stress trig-
gered by YCG063.
5Z-7-oxozeaenol suppressed the induced expression of SELE, ICAM1, VCAM1, CXCL8 and CCL2 by 5.8-, 
4.5-, 15.3-, 20.5-, 2.6-fold, respectively (Fig. 6C). Similarly, YCG063 also downregulated the induced expression 
of SELE, ICAM1, VCAM1, CXCL8, CCL2 by 2.6-, 3.9-, 33.9-, 12.7-, 3.5-fold, respectively (Fig. 6C). Treatment 
with 5z-7-oxozeaenol or YCG063, downregulated the induction of ICAM-1 by 3-fold (Fig. 6D). The increased 
level of VCAM-1 was downregulated by 14.6- and 113.2-fold in response to the treatment with 5z-7-oxozeaenol 
and YCG063, respectively (Fig. 6E). Inhibition of TAK1 or mitochondrial ROS formation resulted in a 1.9- 
and 4.3-fold reduction in the level of IL-8 secretion (Fig. 6F). Under the treatment with 5z-7-oxozeaenol or 
YCG063, the ICAM-1 expression of MEK5D-transduced cells were repressed almost 2-fold (Fig. 6G). VCAM-1 
expression of MEK5D-transduced cells was downregulated by 3.4- and 6.1-fold in response to 5z-7-oxozeaenol 
or YCG063 treatment, respectively (Fig. 6H). Taken together, these data show that TAK1 or generation of 
www.nature.com/scientificreports/
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mitochondrial ROS, or both contribute to oxidative stress and cause upregulation of inflammatory molecules. 
Interestingly, 5z-7-oxozeaenol or YCG063 repressed the upregulation of smooth muscle 22α (SM22α ) 
(see Supplementary Fig. S4), suggesting that the TAK1 pathway and ROS contribute to induction of EndMT20,21 
while exerting inflammatory effects on endothelial cells.
Inhibition of the p38 MAPK or NFκB pathway suppresses inflammatory endothelial pheno-
type. Finally, we dissected the signalling cascades that act downstream of TAK1 and their attenuation of oxi-
dative stress and suppression of endothelial inflammation. Endothelial cells subjected to oxidative stress and 
stimulated with TGF-β 1, were treated with the respective inhibitor of p38 MAPK, SB202190, and of IKKβ , SC514. 
Figure 4. Shear stress abates the activation of canonical TGF-β signalling, independent of the ERK5 
pathway. (A) Immunoblot analyses of ERK5 activation and the expression of KLF2 and KLF4 induced by shear 
stress and MEK5D mutant (representative blots are shown). (B) Shear stress attenuates the phosphorylation of 
SMAD2 induced by TGF-β 1. This suppression is not caused by the reduced level of total SMAD2 (N = 6).  
(C) ERK5 activation under static condition does not suppress the SMAD2 activation. ERK5 activation has no 
effect on the expression of total SMAD2 (N = 4). (D) Shear stress upregulates the expression of SMAD6 and 
SMAD7. TGF-β 1 has no effects on these upregulations (N = 4). (E) ERK5 activation under static condition 
upregulates the expression of SMAD6 and SMAD7. TGF-β 1 has no effects on these upregulations (N = 2). 
*p < 0.05, **p < 0.01, ***p < 0.001 & ****p < 0.0001.
www.nature.com/scientificreports/
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Figure 5. Inhibition of canonical TGF-β signalling reduces oxidative stress, but does not influence the 
expression of ICAM-1, VCAM-1 and IL-8. Attenuation of ALK5 kinase activity reduces the level of (A) 
ROS (N = 3), but has insignificant effects on (B) NO metabolites production (N = 3). (C) ALK5 inhibition 
antagonises the induced expression of ICAM1, CXCL8 and CCL2, but not SELE and VCAM1. ALK5 inhibition 
does not repress the induced protein level of (D) ICAM-1, (E) VCAM-1 and (F) IL-8 (N = 3). The enhanced 
expression of (G) ICAM-1 and (H) VCAM-1 in MEK5D-transduced cells remains unaltered despite the 
inhibition of ALK5 (N = 3). Scale bar represents 50 μ m. *p < 0.05, **p < 0.01 & ***p < 0.001.
www.nature.com/scientificreports/
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Figure 6. Suppression of either TAK1 activation or mitochondrial ROS production represses the 
upregulation of inflammatory molecules. (A) Both 5z-7-oxozeaenol and YCG063 reduce the production of 
ROS (N = 3). (B) 5Z-7-oxozeaenol downregulates the nitrate production, but has little effect on the generation 
of nitrite and nitroso compounds. YCG063 induces the formation nitroso compounds potently, reduces the 
nitrate production and has no effect on the nitrite production (N = 3). Inhibition of TAK1 or suppression of 
mitochondrial ROS generation counteracts the induced expression of (C) SELE, ICAM1, VCAM1, CXCL8 and 
CCL2, as well as (D) ICAM-1, (E) VCAM-1 and (F) IL-8 (N = 3). The induced expression of (G) ICAM-1 and 
(H) VCAM-1 in MEK5D-transduced endothelial cells are repressed by either 5z-7-oxozeaenol or YCG063 
(N = 3). Scale bar represents 50 μ m. *p < 0.05, **p < 0.01, ***p < 0.001 & ****p < 0.0001.
www.nature.com/scientificreports/
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Inhibition of p38 MAPK decreased the induced formation of intracellular ROS by 1.3-fold. Inhibition of IKKβ 
had no effect on ROS formation (Fig. 7A). Inhibition of p38 MAPK or IKKβ had insignificant effect on NO pro-
duction (Fig. 7B). Inhibition of p38 MAPK decreased the induced expression of SELE, ICAM1, VCAM1, CXCL8 
and CCL2 by 5.6-, 10.2-, 18.1-, 8.7- and 7.4-fold (Fig. 7B), respectively. Similarly, IKKβ inhibition also decreased 
the induced expression of SELE (21.5-fold), ICAM1 (13-fold), VCAM1 (38-fold), CXCL8 (20-fold) and CCL2 
(26-fold; Fig. 7C). Taken together, these data suggest that TAK1 activation preferentially activates p38 MAPK or 
NFkB, or both, upon TGF-β 1 stimulation to induce an inflammatory endothelial phenotype.
Discussion
In this study, we dissected the interplay of different components in the network of mechanotransduction which 
suppresses the inflammatory endothelial phenotype. We showed that shear stress-activated ERK5 signalling 
restores the redox state of endothelial cells by adjusting NO and ROS production, but fails to antagonise the 
inflammatory activation by TGF-β 1. Notably, high shear stress counteracts TGF-β 1-induced inflammation by 
suppressing the non-canonical TGF-β pathway via TAK1, in an ERK5-independent manner. This indicates that 
although shear stress-activated ERK5 signalling restores the redox state of endothelial cells, it fails to antagonise 
the inflammatory effects of TGF-β 1. Furthermore, we showed that shear stress abates the kinase activity of ALK5. 
By contrast, in the absence of shear stress, constitutive activation of ERK5 with MEK5D, augmented ALK5 activ-
ity while suppressing both, ROS and NO production. This suggests that suppression of TGF-β signalling by shear 
stress is independent of the ERK5 pathway and redox state (Fig. 8).
Our study suggests that oxidative stress not only contributes to impaired NO bioactivity by scavenging NO, 
but that rates of endothelial ROS and NO production are indeed coupled to maintain proper functioning of 
redox-related signalling including phosphorylation processes; thus, NO production not only compensatorily 
increased upon enhanced oxidative stress, but decreased proportionally upon repression of cellular ROS pro-
duction. Reaction of ROS with NO lead to generation of pro-oxidants, such as peroxynitrite4,22. Peroxynitrite 
and other reactive species can alter endothelial phenotype by disrupting cellular redox signalling, as well as by 
inducing the activation of inflammatory pathways, such as NFκ B and p38 MAPK4 (Fig. 8).
Our study demonstrated that TGF-β 1 aggravates the inflammatory effects of oxidative stress via the 
non-canonical TGF-β pathway. Consistent with others, we showed that activation of ERK5 repressed the induc-
tion of SELE23, CCL2 and IL-812. Intriguingly, upon TGF-β 1 stimulation, ERK5 signalling did not inhibit VCAM-1 
gene and protein expression which decreased when the TAK1 signalling axis was inhibited. AMP-activated pro-
tein kinase (AMPK) mediates shear stress-induced ERK5 signalling, while increasing NO bioavailability and 
reducing oxidative stress24. This mechanistic evidence and our finding link shear stress and the ERK5 pathway 
with redox homeostasis. We suggest that shear stress represses oxidative stress-induced inflammation by restoring 
the redox state via ERK5 pathway, but the suppression of TGF-β 1-induced inflammation depends on inactivation 
Figure 7. Inhibition of either p38 MAPK or NFκB pathway suppresses the upregulation of inflammatory 
molecules. (A) P38 MAPK inhibition reduces ROS production. NFκ B pathway inhibition has no effect on ROS 
production. (N = 3) (B) Both SB202190 and SC514 have insignificant effect on NO metabolites production 
(N = 3). (C) Inhibition of either p38 MAPK or NFκ B pathway suppresses the induced expression of SELE, 
ICAM1, VCAM1, CXCL8 and CCL2 (N = 3). *P < 0.05, **P < 0.01 & ****P < 0.0001.
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of TAK1 signalling (Fig. 8). A selective inhibition of either NFκ B or p38 MAPK downregulated the expression 
of inflammatory molecules. This coincides with earlier findings that TAK1 requires NFκ B25 and p38 MAPK26 
to elicit its downstream effects on endothelial cells (Fig. 8). Activation of TAK1 depends predominantly on the 
affinity of TNF receptor-associated factor 6 (TRAF6) to TGF-β receptor I (Tβ RI), such as ALK5 and stimulation 
of TGF-β receptor II (Tβ RII) by TGF-β 27,28. Therefore, we postulate that shear stress suppresses the activation of 
TAK1 and its downstream pathways by interfering either with the affinity of TRAF6 to ALK5 or with the binding 
of TGF-β 1 to Tβ RII (Fig. 8).
The inhibitory SMADs (SMAD6 and SMAD7) are negative feedback regulators of the TGF-β signalling29. 
Earlier study elucidated KLF2 via upregulation of SMAD7, represses phosphorylation of SMAD219. In our study, 
shear stress-induced SMAD6 and SMAD7 expression correlated with the downregulation of SMAD2 phospho-
rylation, which suggests that shear stress inhibits TGF-β signalling via inhibitory SMADs. Notably, SMAD2 
phosphorylation was not attenuated in our MEK5D-transduced cells, despite the enhanced expression of KLF2, 
SMAD6 and SMAD7. The overexpression of a SMAD2 target gene, TAGLN upon TGF-β stimulation in our study 
explains that the transcriptional activity of SMAD2 in MEK5D-transduced cells was conserved. These data sug-
gest that shear stress inactivates TGF-β signalling in an ERK5-independent manner. We postulate that SMAD6 
and SMAD7 proteins in MEK5D-transduced cells may have been degraded due to SUMO(small ubiquitin-like 
modifier)ylation and ubiquitylation upon TGF-β stimulation30. Alternatively, the post-transcriptional processes 
of these inhibitory SMADs may be affected by microRNAs31.
Collectively, the present study provides compelling evidence that regulation of the endothelial phenotype 
by shear stress involves an intricate crosstalk of multiple signalling axes, rather than an alteration of select indi-
vidual pathways (Fig. 8). Our previous findings elucidated that shear stress mediates EndMT through the ERK5 
pathway17. Here, we show that parallel to signalling through ERK5, which safeguards redox homeostasis, shear 
stress antagonises the inflammatory effects of TGF-β 1 by suppressing the TAK1 pathway (Fig. 8), suggesting that 
shear stress counteracts endothelial dysfunction by activating ERK5 pathway and suppressing TGF-β pathway. 
We propose that the protective effects of shear stress on endothelial cells can be substituted by a pharmacological 
compound that enhances ERK5 signalling and abates TGF-β signalling concurrently.
Materials and Methods
Extended materials and methods are available in supplementary information.
Cell culture, stimulation and inhibition. HUVEC were obtained from Lonza (Breda, The Netherlands) 
and the Endothelial Cell Facility of University Medical Center Groningen, The Netherlands. Cells were main-
tained in endothelial cell medium, composed of, RPMI 1640 basal medium (Lonza, Verviers, Belgium), supple-
mented with 20% heat-inactivated foetal bovine serum (Invitrogen/GIBCO, CA, USA), 50 μ g/ml endothelial cell 
Figure 8. Proposed mechanosignalling crosstalk for regulation of endothelial phenotype by shear stress 
upon oxidative stress and TGF-β1 stimulation. ROS derived from mitochondria reduce NO bioavailability, 
impair NO-mediated signalling and induce the activation of inflammatory signalling, such as NFκ B and 
p38 MAPK pathways. Shear stress attenuates ROS generation and increases NO bioavailability via the ERK5 
pathway. Shear stress represses TGF-β 1-induced inflammatory activation by suppressing p38 MAPK and NFκ 
B signalling which act downstream of TAK1, in a manner independent of ERK5, redox poise and ALK5 kinase 
activity. Shear stress may attenuate the canonical ALK5/SMAD pathway via the upregulation of inhibitory 
SMADs, i.e. SMAD6 and SMAD7.
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growth factors supplement (bovine brain extract; homemade), 1% penicillin-streptomycin (Sigma-Aldrich, MA, 
USA), 2 mM L-glutamine (Lonza) and 5 U/ml heparin (Leo Pharma, Ballerup, Denmark). Cells were used for 
experiments at passage 6 and 7.
Confluent monolayers of HUVEC were stimulated for 48 h with or without 5 or 10 ng/ml citric acid 
activated-TGF-β 1 (Peprotech, NJ, USA; #100–21 C) in RPMI 1640 basal medium, supplemented with 20% 
heat-inactivated foetal bovine serum, 2 mM L-glutamine, 5 U/ml heparin and 1% penicillin-streptomycin. Cells 
treated with endothelial cell medium were harvested as unstimulated controls, Cells were treated with pharmaco-
logical inhibitors for 48 h to inhibit desired signalling pathways.
Shear stress experiments. Confluent monolayer of HUVEC in flow channel, μ -Slide I0.4 Luer (ibidi, 
Martinsried, Germany) were exposed to 20 dynes/cm2 shear stress for 48 h in endothelial cell medium or RPMI 
1640 basal medium, supplemented with 5 or 10 ng/ml TGF-β 1, 20% heat-inactivated foetal bovine serum, 2 mM 
L-glutamine, 5 U/ml heparin and 1% penicillin-streptomycin. Ibidi Pump System was employed for generation of 
laminar flow. Shear stress experiments were performed in an incubator at 37 °C with 5% CO2. Cells treated with 
the same media without exposure to flow were harvested as static controls.
Retroviral transduction. A retroviral construct for stable expression of constitutively active rat MEK5-α 1 
(MEK5D) was generated as described before12. Retroviral transduction of HUVEC was performed as previously 
described17. Expanded transduced cells were seeded for experiments as described for wild type cells.
ROS measurement. Cells were treated with 20 μ M of 2′,7′-dichloroflorescein diacetate (Sigma-Aldrich; 
D6883) and analysed with FACSCaliburTM flow cytometer (BD Biosciences, NJ, USA) at λ max, 520 nm. Average 
intensity was obtained by subtracting the mean fluorescent intensity of unstained samples from stained samples. 
Data of each experimental condition are presented as fold changes in average intensity relative to their respective 
experimental controls.
Quantification of nitrite, nitrate and total nitroso compounds. Cellular formation of NO was 
quantified by the accumulation of nitrite, nitrate and total nitroso compounds in the cell culture media. The 
level of nitrite and nitrate in aliquots of the media was determined using a dedicated analysis system (ENO-
20, EiCom, Japan), as previously described32. The level of nitroso compounds, comprising N-nitrosamines and 
S-nitrosothiols in aliquots of the same media was quantified by gas-phase chemiluminescence, as previously 
described33. Concentration of nitrite (μ M), nitrate (μ M) and nitroso compounds (nM) in each media was nor-
malized to the respective numbers of cell in each experimental condition. Normalised data are presented as fold 
changes in concentration relative to experimental controls.
RNA isolation and RT-qPCR. RNA was isolated with either TRIzol reagent (Invitrogen Corp, CA, 
USA) or RNA-Bee (Bio-Connect, The Netherlands) according to the manufacturer’s protocol. Primer sets (see 
Supplementary Table S1) were used to detect amplimers of interest. Data of each experimental condition are pre-
sented as fold changes in gene expression relative to their respective experimental controls.
Immunofluorescent staining. Mouse anti-human ICAM-1 antibody (hybridoma supernatant; Hu5/3; 
kindly provided by Professor Dr. Michael A. Gimbrone Jr, Harvard Medical School, Boston, MA, USA)34,35 
and SM22α antibody (1:200; Abcam, Cambridge, UK; ab14106) were used. Stained slides were analysed using 
TissueFaxs® Zeiss AxioObserver Z1 Microscope System (TissueGnostics, Vienna, Austria). Mean fluorescent 
intensity quantification was performed with TissueQuest fluorescence analysis software (TissueGnostics). At least 
500 cells were counted for each experimental condition. Data of each experimental condition are presented as fold 
changes in expression relative to their respective experimental controls.
Immunoblotting. Odyssey Immunoblotting System (Li-COR Biosciences, USA) was employed. Antibodies 
against human VCAM-1 (1:100; Santa Cruz Biotechnology, USA; sc-8304), ERK5 (1:500; Upstate Cell Signaling 
Solutions, USA; #07–039), KLF4 (1:500; Santa Cruz Biotechnology; sc-20691), KLF2 (1:500; Santa Cruz 
Biotechnology; sc-28675), p-SMAD2 (Ser465/467; 1:200; Cell Signaling Technology, USA; #3108), SMAD2/3 
(1:200; Cell Signaling Technology; #3102) and GAPDH (1:2000; Abcam, UK; ab9484) were used for detection of 
target proteins. Expression of target proteins was normalised to loading control, GAPDH. Data of each experi-
mental condition are presented as fold changes in expression relative to their respective experimental controls.
Sandwich enzyme-linked immunosorbent assay (ELISA). Culture media of different experimental con-
dition were collected. Concentration of IL-8 in media was quantified with Human IL-8 ELISA MAXTM Standard 
Sets (BioLegend Inc, CA, USA) according to the manufacturer’s protocol. Concentration of IL-8 in each media was 
normalized to their respective numbers of cell in each experimental condition. Data of each experimental condition 
are presented as fold changes in IL-8 concentration (pg/ml) relative to their respective experimental controls.
Statistical Analysis. All experimental data were obtained from two to seven independent experiments with 
duplicates or triplicates. All data are presented as means + standard error of the mean (SEM). Statistical analyses 
were performed with GraphPad Prism (Version 6.01; GraphPad Software, Inc., USA). For two-group compari-
sons, two-tailed ratio paired t test was performed. For multiple group comparisons, one-way analysis of variance 
(ANOVA) followed by Sidak’s post-test were carried out. For multiple categorical group comparisons, two-way 
ANOVA followed by Sidak’s post-test were executed. All statistical analyses were performed at the 95% of confidence 
interval. Differences between means were considered significant when probabilities (P) were less than 0.05.
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